← Leaderboards
Jonathan Douglas Santoro
Children'S Hospital Of Los Angeles
$2,588,701
Attributed
$4,341,075
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2021–25$2M$1.5M$1M$500K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,341,075 · 4
By mechanism
R61$1,545,428 · 1
K23$1,267,566 · 1
R25$866,506 · 1
R01$661,575 · 1
Top collaborators
- Joaquin M. Espinosa2 shared
- Elise M Sannar2 shared
- Ann D. Cohen1 shared
- Benjamin L Handen1 shared
- Elizabeth Head1 shared
- Adam Cain Resnick1 shared
- Gerald Schatten1 shared
Most similar at Children'S Hospital Of Los Angeles
Same institution · by research overlap
- Ashok Panigrahy$5,281,634
Others in their field
Other Emerging Leaders on “Investigation”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Chanza Baytop · Westat, Inc.$271,217,917
- Joel A Lipkin · Four Points Technology, Llc$178,737,225
- Leonard Freedman · Leidos Biomedical Research, Inc.$132,914,619
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$93,329,356
Research focus
InvestigationBiological MarkersResponseClinical TrialsNeuroimagingMagnetic Resonance ImagingDiagnosisUnited StatesNeurologicTherapeutic InterventionModalityLinkMeasurementScientistEtiologyImmunePrevalenceCohortBiometryGenetic DiseasesMentorsMoyamoya DiseaseInflammationInflammatory
Grant awards (13)
INCLUDE Clinical Researcher Training (ICRT)$866,506
R25 · FY2025 · AG
Neurodiagnostic, Proteomic, and Metabolomic Investigations into Down Syndrome Regression Disorder$661,575
R01 · FY2025 · HD · contact PI
Non-invasive biometric screening for cerebrovascular disorders in persons with Down syndrome.$258,285
K23 · FY2025 · HL · contact PI
Non-invasive biometric screening for cerebrovascular disorders in persons with Down syndrome.$60,000
K23 · FY2025 · HL · contact PI
Non-invasive biometric screening for cerebrovascular disorders in persons with Down syndrome.$192,671
K23 · FY2024 · HL · contact PI
Non-invasive biometric screening for cerebrovascular disorders in persons with Down syndrome.$62,517
K23 · FY2024 · HL · contact PI
Non-invasive biometric screening for cerebrovascular disorders in persons with Down syndrome.$60,000
K23 · FY2024 · HL · contact PI
Mechanistic investigation of therapies for Down Syndrome Regression Disorder$1,176,407
R61 · FY2023 · HD
Non-invasive biometric screening for cerebrovascular disorders in persons with Down syndrome.$192,741
K23 · FY2023 · HL · contact PI
Non-invasive biometric screening for cerebrovascular disorders in persons with Down syndrome.$62,517
K23 · FY2023 · HL · contact PI
Mechanistic investigation of therapies for Down Syndrome Regression Disorder$369,021
R61 · FY2022 · HD
Non-invasive biometric screening for cerebrovascular disorders in persons with Down syndrome.$185,276
K23 · FY2022 · HL · contact PI
Non-invasive biometric screening for cerebrovascular disorders in persons with Down syndrome.$193,559
K23 · FY2021 · HL · contact PI